Chiral Resolution, Absolute Configuration Assignment, and Genotoxicity Evaluation of Racemic 3,4-Dihydroquinazoline as a Novel Anticancer Agent

<div>Experimental and TDDFT-calculated ECD spectrum of <i>R</i>-(<b>−</b>)-<b>KCP-10043F</b>.</div>

Journal of Chemistry

fig5

Figure 5

Figure 5: Chiral Resolution, Absolute Configuration Assignment, and Genotoxicity Evaluation of Racemic 3,4-Dihydroquinazoline as a Novel Anticancer Agent 

Figure 5 | Chiral Resolution, Absolute Configuration Assignment, and Genotoxicity Evaluation of Racemic 3,4-Dihydroquinazoline as a Novel Anticancer Agent 